14.03.2024
Scaling Impact: Skagerak Capital presented impact contributions from investments at Slush’d Energy

At Slush’d Energy, a gathering of leading founders, leaders, investors, and companies who are committed to accelerate the transition to a cleaner and more sustainable future, Skagerak Capital hosted an investor lounge. The lounge featured keynotes and panel discussions on the topics of impact investing and the opportunities within AI. Andreas Eskeland, investment partner at Skagerak Capital, delivered a keynote on the significant impact from Skagerak Capital's investments.

Looking at the Skagerak Capital investments, at the time of the keynote consisting of 31 companies, 100 % of these are classified as ESG compliant - meaning contribution to one or more of the United Nations Sustainable Development Goals and that they do no significant harm to the same goals. The ESG compliance assessment is conducted at the time of investments and maintained throughout the development and growth of the companies, until exit.

4 out of 5 portfolio companies contribute with positive impact. Positive impact is defined as having significant positive effects on its surroundings - e.g. the environment or human health. This positive impact scales with the business model and is closely correlated with the economic business case for the customers of the portfolio companies.

Notably, more than 50 % of portfolio companies contribute to CO2 reduction efforts, yielding significant annual CO2 savings. Current annual run rate of reported CO2 savings from investments accumulate to more than 50.000 tons of CO2 reduction, when adjusting for ownership. These savings are expected to continue to grow as the portfolio companies are scaling.

Examples of companies with significant impact, other than directly contributing to CO2 savings, include Vilmer who contribute to 100 000 happy moments to elderly in nursing homes annually and combat loneliness, and ECG247 which saves lives and prevents strokes through its affordable, easy to use and continuous long-term cardiac monitoring.